GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » NovelStem International Corp (OTCPK:NSTM) » Definitions » Cyclically Adjusted Price-to-FCF

NovelStem International (NovelStem International) Cyclically Adjusted Price-to-FCF : (As of May. 17, 2024)


View and export this data going back to 1995. Start your Free Trial

What is NovelStem International Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


NovelStem International Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for NovelStem International's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NovelStem International Cyclically Adjusted Price-to-FCF Chart

NovelStem International Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NovelStem International Quarterly Data
Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of NovelStem International's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, NovelStem International's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NovelStem International's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NovelStem International's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where NovelStem International's Cyclically Adjusted Price-to-FCF falls into.



NovelStem International Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

NovelStem International's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, NovelStem International's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.002/129.4194*129.4194
=-0.002

Current CPI (Dec. 2023) = 129.4194.

NovelStem International Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200606 -0.046 85.606 -0.070
200609 -0.033 85.606 -0.050
200612 0.020 85.142 0.030
200703 -0.131 86.640 -0.196
200706 -0.031 87.906 -0.046
200709 -0.107 87.964 -0.157
200712 -0.081 88.616 -0.118
200803 -0.094 90.090 -0.135
200806 -0.072 92.320 -0.101
200809 -0.127 92.307 -0.178
200812 0.027 88.697 0.039
200903 -0.057 89.744 -0.082
200906 -0.077 91.003 -0.110
200909 0.033 91.120 0.047
200912 0.227 91.111 0.322
201003 -0.003 91.821 -0.004
201006 -0.124 91.962 -0.175
201009 -0.020 92.162 -0.028
201012 0.270 92.474 0.378
201103 -0.069 94.283 -0.095
201106 -0.043 95.235 -0.058
201109 0.036 95.727 0.049
201112 -0.027 95.213 -0.037
201203 -0.021 96.783 -0.028
201206 -0.040 96.819 -0.053
201209 -0.027 97.633 -0.036
201212 -0.084 96.871 -0.112
201303 -0.059 98.209 -0.078
201306 -0.041 98.518 -0.054
201309 -0.054 98.790 -0.071
202109 0.000 115.734 0.000
202112 -0.001 117.630 -0.001
202203 0.004 121.301 0.004
202206 -0.003 125.017 -0.003
202209 -0.003 125.227 -0.003
202212 -0.003 125.222 -0.003
202303 -0.001 127.348 -0.001
202306 -0.004 128.729 -0.004
202309 -0.002 129.860 -0.002
202312 -0.002 129.419 -0.002

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


NovelStem International  (OTCPK:NSTM) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


NovelStem International Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of NovelStem International's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


NovelStem International (NovelStem International) Business Description

Traded in Other Exchanges
N/A
Address
2255 Glades Road, Suite 221A, Boca Raton, FL, USA, 33431
NovelStem International Corp owns novel stem-cell-based diagnostic technology for predicting patients' resistance to cancer therapies. The technology is also being used for genetic research related to other medical therapies.
Executives
Baker Street Capital Management, Llc 10 percent owner 1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067
Vadim Perelman 10 percent owner 1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067
Baker Street Capital L.p. 10 percent owner 1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067
Stephen Gans director, 10 percent owner 14850 NW 44TH COURT, OPA LOCKA FL 33054
Shannon River Partners Lp 10 percent owner 850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022
Shannon River Fund Management Co Llc 10 percent owner 850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022
Shannon River Partners Ii, Lp 10 percent owner 850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022
Doonbeg Fund Lp 10 percent owner 850 THIRD AVE, 13TH FLOOR, New York ny 10022
Spencer M. Waxman director C/O SHANNON RIVER PARTNERS, 800 THIRD AVENUE 30TH FLOOR, NEW YORK NY 10022
Stanley Morgan 10 percent owner 1585 BROADWAY, NEW YORK NY 10036
Robert D. Epstein director 2255 GLADES ROAD, BOCA RATON FL 33431
Coghill Capital Management Llc 10 percent owner 233 SOUTH WACKER DRIVE, SUITE 8439, CHICAGO IL 60606
Ccm Master Fund Ltd 10 percent owner C/O MORGAN STANLEY FUND SERVICES (CAYMAN, LTD CENTURY YARD CRICKET SQ HUTCHINGS DR, PO BOX 2681 GEORGE TOWN E9 00000
Clint D Coghill 10 percent owner
Scott Gomez officer: Chief Accounting Officer

NovelStem International (NovelStem International) Headlines

From GuruFocus

NewStem Announces $4 million Seed Investment

By PRNewswire PRNewswire 07-16-2018